ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mahadeva, R
Right arrow Articles by Lomas, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahadeva, R
Right arrow Articles by Lomas, D.
Eur Respir J 1998; 11: 873-879
Copyright © ERS Journals Ltd 1998

Original Articles

Alpha1-antitrypsin deficiency alleles and the Taq-I G-->A allele in cystic fibrosis lung disease

R Mahadeva, RC Westerbeek, DJ Perry, JU Lovegrove, DB Whitehouse, NR Carroll, RI Ross-Russell, AK Webb, D Bilton, and DA Lomas

Cystic fibrosis (CF) is characterized by progressive and ultimately fatal pulmonary disease although there are notable variations in clinical features. This heterogeneity is thought to lie outside the cystic fibrosis transmembrane regulator (CFTR) gene locus and may stem from deficiencies in the antiproteinase screen that protects the lung from proteolytic attack. One hundred and fifty seven patients were recruited from two UK CF centres. The serum concentrations of alpha1-antitrypsin, alpha1-antichymotrypsin and C-reactive protein (CRP) were determined and patients were screened for the common S and Z deficiency alleles of alpha1-antitrypsin and the G-->A mutation in the 3' noncoding region of the alpha1-antitrypsin gene (Taq-I G-->A allele). Alpha1-antitrypsin deficiency phenotypes were detected in 20 (16 MS, 1 S and 3 MZ) out of 147 unrelated tested CF patients and were, surprisingly, associated with significantly better lung function (adjusted mean forced expiratory volume in one second (FEV1) 62.5% of predicted for deficient group and 51.1% pred for normal alleles; p=0.043). The Taq-I G-->A allele was found in 21 out of 150 unrelated patients and had no significant effect on CF lung disease or on levels of alpha1-antitrypsin during the inflammatory response. We show here that, contrary to current thinking, common mutations of alpha1-antitrypsin that are associated with mild to moderate deficiency of the protein predict a subgroup of cystic fibrosis patients with less severe pulmonary disease. Moreover, the Taq-I G-->A allele has no effect on serum levels of alpha1-antitrypsin in the inflammatory response, which suggests that the previously reported association of the Taq-I G-->A allele with chronic obstructive pulmonary disease is not mediated by its effect on the serum level of alpha1-antitrypsin.


This article has been cited by other articles:


Home page
 Clin. Chem.Home page
D. Roche, A. Mesner, M. Al Nakib, F. Leonard, and P. Beaune
Automated Determination of Serum {alpha}1-Antitrypsin by Antitryptic Activity Measurement
Clin. Chem., March 1, 2009; 55(3): 513 - 518.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. L. Drumm, M. W. Konstan, M. D. Schluchter, A. Handler, R. Pace, F. Zou, M. Zariwala, D. Fargo, A. Xu, J. M. Dunn, et al.
Genetic Modifiers of Lung Disease in Cystic Fibrosis
N. Engl. J. Med., October 6, 2005; 353(14): 1443 - 1453.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
D. D. Frangolias, J. Ruan, P. J. Wilcox, A. G. F. Davidson, L. T. K. Wong, Y. Berthiaume, R. Hennessey, A. Freitag, L. Pedder, M. Corey, et al.
{alpha}1-Antitrypsin Deficiency Alleles in Cystic Fibrosis Lung Disease
Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): 390 - 396.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
H Witt
Chronic pancreatitis and cystic fibrosis
Gut, May 1, 2003; 52(90002): ii31 - 41.
[Abstract] [Full Text]

Home page
 ThoraxHome page
A J Sandford and E K Silverman
Chronic obstructive pulmonary disease * 1: Susceptibility factors for COPD the genotype-environment interaction
Thorax, August 1, 2002; 57(8): 736 - 741.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
M. Dahl, A. Tybjaerg-Hansen, P. Lange, J. Vestbo, and B. G. Nordestgaard
Change in Lung Function and Morbidity from Chronic Obstructive Pulmonary Disease in {alpha}1-Antitrypsin MZ Heterozygotes: A Longitudinal Study of the General Population
Ann Intern Med, February 19, 2002; 136(4): 270 - 279.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
R. MAHADEVA and D. A LOMAS
Secondary genetic factors in cystic fibrosis lung disease
Thorax, June 1, 2000; 55(6): 446 - 446.
[Full Text]

Home page
 ThoraxHome page
R Mahadeva, S Stewart, D Bilton, and D A Lomas
Alpha-1 antitrypsin deficiency alleles and severe cystic fibrosis lung disease
Thorax, December 1, 1998; 53(12): 1022 - 1024.
[Abstract] [Full Text]

Home page
 BMJHome page
R. Mahadeva, K. Webb, R. C Westerbeek, N. R Carroll, M. E Dodd, D. Bilton, D. A Lomas, J A Dodge, M. Egger, N. Low, et al.
Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study • Commentary: Management in paediatric and adult cystic fibrosis centres improves clinical outcome • Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis
BMJ, June 13, 1998; 316(7147): 1771 - 1780.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the European Respiratory Society.